Bluetongue serotype 3 vaccine advisory note for veterinarians
Advisory note from the UK Chief Veterinary Officer for veterinarians prescribing BTV-3 vaccines.
Applies to England, Scotland and Wales
Documents
Details
Three BTV-3 vaccines have been permitted for use. Two of these have been granted a marketing authorisation by the Veterinary Medicines Directorate (VMD), and the third is unauthorised. You can only use these vaccines if your use is compliant with a valid licence or declaration. Vets must read the advisory note before prescribing any BTV-3 vaccine.
The UK Chief Veterinary Officer asks vets to record all vaccines prescribed to support our analysis of this disease and its vaccines, and to inform relevant authorities of any adverse effects.
You can read more about BTV-3 vaccine rules, limitations, permits and licences, or information on how your data is stored.
Updates to this page
-
Two BTV-3 vaccines have been granted marketing authorisation by the Veterinary Medicines Directorate. Unauthorised vaccines can continue to be imported into Great Britain (England, Scotland and Wales) until October 2025. You can continue to use unauthorised vaccines under permit until their expiry date, as long as they were bought on the British market.
-
Updated the email address that veterinarians should use to notify Defra when they have prescribed a BTV-3 vaccine. They should now email btv3vaccine@defra.gov.uk
-
First published.